4.9 (133) · $ 6.50 · In stock
A randomized trial comparing the platinum-chromium everolimus-eluting stent to the cobalt-chromium everolimus-eluting stent in 2980 all-comers patients undergoing PCI, finding the platinum-chromium stent noninferior for target vessel failure at 1 year.
Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial
PDF) A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre
Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation
The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre
PDF) A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
PDF) A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
PDF) A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
Left bundle branch block after sutureless, transcatheter, and stented biological aortic valve replacement for aortic stenosis